Search for: "MERRELL v. U.S."
Results 41 - 60
of 383
Sort by Relevance
|
Sort by Date
15 Jan 2021, 12:24 pm
Supreme Court case of Daubert v. [read post]
19 Nov 2020, 3:18 pm
Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). [read post]
1 Oct 2020, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Frye test was the predominant standard for the admissibility of scientific evidence in state and federal courts. [read post]
21 Sep 2020, 3:04 pm
However, in the 1990s, in response to a U.S. [read post]
10 Jul 2020, 2:08 pm
’” Richardson-Merrell, 472 U.S. at431 (quoting Coopers & Lybrand v. [read post]
9 Jul 2020, 9:09 am
’” Richardson-Merrell, Inc. v. [read post]
29 Jun 2020, 12:41 pm
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), and the testimony is helpful to the trier of fact to understand the evidence through specialized, scientific, or technical expertise. [read post]
3 Jun 2020, 11:49 am
Allen v. [read post]
2 Jun 2020, 12:54 am
Co. v. [read post]
13 May 2020, 2:03 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 n.10 (1993). [3] Id., citing Bourjaily v. [read post]
11 May 2020, 1:09 am
In the face of this traditional judicial lassitude, “[v]igorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof” were all a litigant could hope to accomplish in litigation. [read post]
8 May 2020, 3:47 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2] Frye v. [read post]
7 May 2020, 1:04 pm
Daubert refers to the U.S. [read post]
13 Feb 2020, 9:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and thus should not have been admitted nor relied upon. [read post]
12 Feb 2020, 5:29 pm
Merrell Dow Pharmaceuticals. [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
28 Dec 2019, 4:00 am
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993). [read post]
18 Oct 2019, 10:02 am
Merrell Dow Pharms. and the Texas Supreme Court in E.I. du Pont de Nemours v. [read post]
8 Oct 2019, 2:25 pm
Merrell Dow Pharm., Inc., 509 U.S. 579, 589–95 (1993); see also Goebel v. [read post]
